-
1
-
-
33750603100
-
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
-
Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-44.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4539-4544
-
-
Govindan, R.1
Page, N.2
Morgensztern, D.3
-
2
-
-
84887608250
-
Globocan: Cancer Fact Sheets
-
Available online
-
Globocan: Cancer Fact Sheets. Available online: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
-
-
-
-
3
-
-
84860294779
-
Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies
-
Pesch B, Kendzia B, Gustavsson P, et al. Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer 2012;131:1210-9.
-
(2012)
Int J Cancer
, vol.131
, pp. 1210-1219
-
-
Pesch, B.1
Kendzia, B.2
Gustavsson, P.3
-
4
-
-
75749108918
-
Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis
-
Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.
-
(2010)
BMJ
, vol.340
, pp. b5569
-
-
Parsons, A.1
Daley, A.2
Begh, R.3
-
5
-
-
0002127873
-
Lung Biology in Health and Disease
-
Samet JM, editor., New York: Marcel Dekker Inc.
-
Churg A. Lung Biology in Health and Disease. In: Samet JM, editor. Epidemiology of Lung-Cancer. New York: Marcel Dekker Inc., 1994:413-36.
-
(1994)
Epidemiology of Lung-Cancer.
, pp. 413-436
-
-
Churg, A.1
-
6
-
-
0015861452
-
Keynote address on biostatistics and data retrieval
-
Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 3 1973;4:31-42.
-
(1973)
Cancer Chemother Rep 3
, vol.4
, pp. 31-42
-
-
Zelen, M.1
-
8
-
-
37349068491
-
The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer
-
Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007;2:1067-77.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 1067-1077
-
-
Shepherd, F.A.1
Crowley, J.2
Van Houtte, P.3
-
10
-
-
79952408951
-
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials
-
Foster NR, Qi Y, Shi Q, et al. Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials. Cancer 2011;117:1262-71.
-
(2011)
Cancer
, vol.117
, pp. 1262-1271
-
-
Foster, N.R.1
Qi, Y.2
Shi, Q.3
-
11
-
-
84857338470
-
Management of small cell lung cancer: recent developments for optimal care
-
Califano R, Abidin AZ, Peck R, et al. Management of small cell lung cancer: recent developments for optimal care. Drugs 2012;72:471-90.
-
(2012)
Drugs
, vol.72
, pp. 471-490
-
-
Califano, R.1
Abidin, A.Z.2
Peck, R.3
-
12
-
-
77649142718
-
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer
-
Yu JB, Decker RH, Detterbeck FC, et al. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010;5:215-9.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 215-219
-
-
Yu, J.B.1
Decker, R.H.2
Detterbeck, F.C.3
-
14
-
-
58949089257
-
The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate
-
Lim E, Belcher E, Yap YK, et al. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol 2008;3:1267-71.
-
(2008)
J Thorac Oncol
, vol.3
, pp. 1267-1271
-
-
Lim, E.1
Belcher, E.2
Yap, Y.K.3
-
15
-
-
84960101743
-
NCCN Guidelines Version 1.2016 Small Cell Lung Cancer.
-
Available online
-
NCCN Guidelines Version 1. 2016 Small Cell Lung Cancer. Available online: http://www.nccn.org/ professionals/physician_gls/pdf/sclc.pdf
-
-
-
-
16
-
-
0023876085
-
Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung
-
Shepherd FA, Evans WK, Feld R, et al. Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung. J Clin Oncol 1988;6:832-8.16
-
(1988)
J Clin Oncol
, vol.6
, pp. 832-838
-
-
Shepherd, F.A.1
Evans, W.K.2
Feld, R.3
-
17
-
-
18244364827
-
Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)
-
Tsuchiya R, Suzuki K, Ichinose Y, et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 2005;129:977-83.
-
(2005)
J Thorac Cardiovasc Surg
, vol.129
, pp. 977-983
-
-
Tsuchiya, R.1
Suzuki, K.2
Ichinose, Y.3
-
18
-
-
0023204297
-
Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial
-
Bunn PA Jr, Lichter AS, Makuch RW, et al. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med 1987;106:655-62.
-
(1987)
Ann Intern Med
, vol.106
, pp. 655-662
-
-
Bunn, P.A.1
Lichter, A.S.2
Makuch, R.W.3
-
19
-
-
0023112256
-
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung
-
Perry MC, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987;316:912-8.
-
(1987)
N Engl J Med
, vol.316
, pp. 912-918
-
-
Perry, M.C.1
Eaton, W.L.2
Propert, K.J.3
-
20
-
-
0026482388
-
A meta-analysis of thoracic radiotherapy for small-cell lung cancer
-
Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618-24.
-
(1992)
N Engl J Med
, vol.327
, pp. 1618-1624
-
-
Pignon, J.P.1
Arriagada, R.2
Ihde, D.C.3
-
21
-
-
0026716516
-
Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis
-
Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;10:890-5.
-
(1992)
J Clin Oncol
, vol.10
, pp. 890-895
-
-
Warde, P.1
Payne, D.2
-
22
-
-
0027399457
-
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group
-
Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993;11:336-44.
-
(1993)
J Clin Oncol
, vol.11
, pp. 336-344
-
-
Murray, N.1
Coy, P.2
Pater, J.L.3
-
23
-
-
0037099617
-
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104
-
Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002;20:3054-60.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3054-3060
-
-
Takada, M.1
Fukuoka, M.2
Kawahara, M.3
-
24
-
-
16244389133
-
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
-
Fried DB, Morris DE, Poole C, et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004;22:4837-45.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4837-4845
-
-
Fried, D.B.1
Morris, D.E.2
Poole, C.3
-
25
-
-
34548206333
-
Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and metaanalysis of randomised controlled trials
-
Pijls-Johannesma M, De Ruysscher D, Vansteenkiste J, et al. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and metaanalysis of randomised controlled trials. Cancer Treat Rev 2007;33:461-73.
-
(2007)
Cancer Treat Rev
, vol.33
, pp. 461-473
-
-
Pijls-Johannesma, M.1
De Ruysscher, D.2
Vansteenkiste, J.3
-
26
-
-
84896724080
-
Progress in the management of limited-stage small cell lung cancer
-
Amini A, Byers LA, Welsh JW, et al. Progress in the management of limited-stage small cell lung cancer. Cancer 2014;120:790-8.
-
(2014)
Cancer
, vol.120
, pp. 790-798
-
-
Amini, A.1
Byers, L.A.2
Welsh, J.W.3
-
27
-
-
84893240166
-
Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer
-
Ha IB, Jeong BK, Jeong H, et al. Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer. Radiat Oncol J 2013;31:185-90.
-
(2013)
Radiat Oncol J
, vol.31
, pp. 185-190
-
-
Ha, I.B.1
Jeong, B.K.2
Jeong, H.3
-
28
-
-
33645304581
-
Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer
-
De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, et al. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 2006;17:543-52.
-
(2006)
Ann Oncol
, vol.17
, pp. 543-552
-
-
De Ruysscher, D.1
Pijls-Johannesma, M.2
Vansteenkiste, J.3
-
29
-
-
84881233811
-
Phase III trial of concurrent thoracic radiotherapy with either first-or third-cycle chemotherapy for limited-disease small-cell lung cancer
-
Sun JM, Ahn YC, Choi EK, et al. Phase III trial of concurrent thoracic radiotherapy with either first-or third-cycle chemotherapy for limited-disease small-cell lung cancer. Ann Oncol 2013;24:2088-92.
-
(2013)
Ann Oncol
, vol.24
, pp. 2088-2092
-
-
Sun, J.M.1
Ahn, Y.C.2
Choi, E.K.3
-
30
-
-
0037115426
-
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up
-
Sundstrøm S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol 2002;20:4665-72.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4665-4672
-
-
Sundstrøm, S.1
Bremnes, R.M.2
Kaasa, S.3
-
31
-
-
0034129381
-
Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent
-
Pujol JL, Carestia L, Daurès JP. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer 2000;83:8-15.
-
(2000)
Br J Cancer
, vol.83
, pp. 8-15
-
-
Pujol, J.L.1
Carestia, L.2
Daurès, J.P.3
-
32
-
-
0033611522
-
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
-
Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-71.
-
(1999)
N Engl J Med
, vol.340
, pp. 265-271
-
-
Turrisi, A.T.1
Kim, K.2
Blum, R.3
-
33
-
-
84862698258
-
Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239
-
Komaki R, Paulus R, Ettinger DS, et al. Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239. Int J Radiat Oncol Biol Phys 2012;83:e531-6.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.83
, pp. e531-e536
-
-
Komaki, R.1
Paulus, R.2
Ettinger, D.S.3
-
34
-
-
84960098165
-
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
-
Available online
-
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide. Available online: https://clinicaltrials.gov/ct2/show/NCT00632853
-
-
-
-
35
-
-
0033777777
-
Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis
-
Hochstenbag MM, Twijnstra A, Wilmink JT, et al. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol 2000;48:243-8.
-
(2000)
J Neurooncol
, vol.48
, pp. 243-248
-
-
Hochstenbag, M.M.1
Twijnstra, A.2
Wilmink, J.T.3
-
36
-
-
0028910241
-
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
-
Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995;87:183-90.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 183-190
-
-
Arriagada, R.1
Le Chevalier, T.2
Borie, F.3
-
37
-
-
0028894203
-
Prophylactic Cranial Irradiation: More Questions Than Answers
-
Ball DL, Matthews JP. Prophylactic Cranial Irradiation: More Questions Than Answers. Semin Radiat Oncol 1995;5:61-68.
-
(1995)
Semin Radiat Oncol
, vol.5
, pp. 61-68
-
-
Ball, D.L.1
Matthews, J.P.2
-
38
-
-
0022373125
-
Social consequences of brain or liver relapse in small cell carcinoma of the bronchus
-
Felletti R, Souhami RL, Spiro SG, et al. Social consequences of brain or liver relapse in small cell carcinoma of the bronchus. Radiother Oncol 1985;4:335-9.
-
(1985)
Radiother Oncol
, vol.4
, pp. 335-339
-
-
Felletti, R.1
Souhami, R.L.2
Spiro, S.G.3
-
39
-
-
1942471657
-
Prophylactic cranial irradiation in small cell lung cancer
-
Le Péchoux C, Arriagada R. Prophylactic cranial irradiation in small cell lung cancer. Hematol Oncol Clin North Am 2004;18:355-72.
-
(2004)
Hematol Oncol Clin North Am
, vol.18
, pp. 355-372
-
-
Le Péchoux, C.1
Arriagada, R.2
-
40
-
-
3042759877
-
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
-
Meert AP, Paesmans M, Berghmans T, et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001;1:5.
-
(2001)
BMC Cancer
, vol.1
, pp. 5
-
-
Meert, A.P.1
Paesmans, M.2
Berghmans, T.3
-
41
-
-
0345062339
-
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group
-
Aupérin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-84.
-
(1999)
N Engl J Med
, vol.341
, pp. 476-484
-
-
Aupérin, A.1
Arriagada, R.2
Pignon, J.P.3
-
42
-
-
65449145578
-
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial
-
Le Péchoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 2009;10:467-74.
-
(2009)
Lancet Oncol
, vol.10
, pp. 467-474
-
-
Le Péchoux, C.1
Dunant, A.2
Senan, S.3
-
43
-
-
0036138258
-
Prophylactic cranial irradiation revisited: cost-effectiveness and quality of life in small-cell lung cancer
-
Tai TH, Yu E, Dickof P, et al. Prophylactic cranial irradiation revisited: cost-effectiveness and quality of life in small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52:68-74.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 68-74
-
-
Tai, T.H.1
Yu, E.2
Dickof, P.3
-
44
-
-
33747054805
-
Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer
-
Lee JJ, Bekele BN, Zhou X, et al. Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 2006;24:3597-603.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3597-3603
-
-
Lee, J.J.1
Bekele, B.N.2
Zhou, X.3
-
45
-
-
0022409779
-
VP-16 and cisplatin as first-line therapy for small-cell lung cancer
-
Evans WK, Shepherd FA, Feld R, et al. VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol 1985;3:1471-7.
-
(1985)
J Clin Oncol
, vol.3
, pp. 1471-1477
-
-
Evans, W.K.1
Shepherd, F.A.2
Feld, R.3
-
46
-
-
0036230962
-
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study
-
Hanna NH, Sandier AB, Loehrer PJ Sr, et al. Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study. Ann Oncol 2002;13:95-102.
-
(2002)
Ann Oncol
, vol.13
, pp. 95-102
-
-
Hanna, N.H.1
Sandier, A.B.2
Loehrer, P.J.3
-
47
-
-
33846013518
-
Temporal trends in small cell lung cancer: Analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database
-
Navada S, Lai P, Schwartz AG, et al. Temporal trends in small cell lung cancer: Analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database. J Clin Oncol 2006;24:abstr 7082.
-
(2006)
J Clin Oncol
, vol.24
-
-
Navada, S.1
Lai, P.2
Schwartz, A.G.3
-
48
-
-
84909698019
-
Clinical management of patients with small cell lung cancer
-
Greco FA, Oldham RK, Bunn PA, editors., New York: Grune and Stratton
-
Greco FA, Oldham RK. Clinical management of patients with small cell lung cancer. In: Greco FA, Oldham RK, Bunn PA, editors. Small Cell Lung Cancer. New York: Grune and Stratton, 1981:353-379.
-
(1981)
Small Cell Lung Cancer.
, pp. 353-379
-
-
Greco, F.A.1
Oldham, R.K.2
-
49
-
-
34547937885
-
Prophylactic cranial irradiation in extensive small-cell lung cancer
-
Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-72.
-
(2007)
N Engl J Med
, vol.357
, pp. 664-672
-
-
Slotman, B.1
Faivre-Finn, C.2
Kramer, G.3
-
50
-
-
0033016449
-
Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study
-
Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study. J Clin Oncol 1999;17:2092-9.
-
(1999)
J Clin Oncol
, vol.17
, pp. 2092-2099
-
-
Jeremic, B.1
Shibamoto, Y.2
Nikolic, N.3
-
51
-
-
81755161544
-
Thoracic radiation therapy improves the overall survival of patients with extensivestage small cell lung cancer with distant metastasis
-
Zhu H, Zhou Z, Wang Y, et al. Thoracic radiation therapy improves the overall survival of patients with extensivestage small cell lung cancer with distant metastasis. Cancer 2011;117:5423-31.
-
(2011)
Cancer
, vol.117
, pp. 5423-5431
-
-
Zhu, H.1
Zhou, Z.2
Wang, Y.3
-
52
-
-
80155167117
-
Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy
-
Giuliani ME, Atallah S, Sun A, et al. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy. Clin Lung Cancer 2011;12:375-9.
-
(2011)
Clin Lung Cancer
, vol.12
, pp. 375-379
-
-
Giuliani, M.E.1
Atallah, S.2
Sun, A.3
-
53
-
-
84920502676
-
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase III randomised controlled trial
-
Slotman BJ, van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase III randomised controlled trial. Lancet 2015;385:36-42.
-
(2015)
Lancet
, vol.385
, pp. 36-42
-
-
Slotman, B.J.1
Van Tinteren, H.2
Praag, J.O.3
-
54
-
-
0017873236
-
Smallcell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study
-
Livingston RB, Moore TN, Heilbrun L, et al. Smallcell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study. Ann Intern Med 1978;88:194-9.
-
(1978)
Ann Intern Med
, vol.88
, pp. 194-199
-
-
Livingston, R.B.1
Moore, T.N.2
Heilbrun, L.3
-
55
-
-
0019476335
-
Combined modality treatment of small cell carcinoma of the lung
-
Feld R, Pringle JF, Evans WK, et al. Combined modality treatment of small cell carcinoma of the lung. Arch Intern Med 1981;141:469-73.
-
(1981)
Arch Intern Med
, vol.141
, pp. 469-473
-
-
Feld, R.1
Pringle, J.F.2
Evans, W.K.3
-
56
-
-
0018728239
-
The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma
-
Lowenbraun S, Bartolucci A, Smalley RV, et al. The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma. Cancer 1979;44:406-13.
-
(1979)
Cancer
, vol.44
, pp. 406-413
-
-
Lowenbraun, S.1
Bartolucci, A.2
Smalley, R.V.3
-
57
-
-
0030608237
-
Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party
-
Girling DJ. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party. Lancet 1996;348:563-6.
-
(1996)
Lancet
, vol.348
, pp. 563-566
-
-
Girling, D.J.1
-
58
-
-
0030946011
-
Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy
-
Souhami RL, Spiro SG, Rudd RM, et al. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst 1997;89:577-80.
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 577-580
-
-
Souhami, R.L.1
Spiro, S.G.2
Rudd, R.M.3
-
59
-
-
0036753660
-
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588)
-
Ettinger DS, Finkelstein DM, Ritch PS, et al. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588). Lung Cancer 2002;37:311-8.
-
(2002)
Lung Cancer
, vol.37
, pp. 311-318
-
-
Ettinger, D.S.1
Finkelstein, D.M.2
Ritch, P.S.3
-
60
-
-
0033797356
-
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
-
Mascaux C, Paesmans M, Berghmans T, et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000;30:23-36.
-
(2000)
Lung Cancer
, vol.30
, pp. 23-36
-
-
Mascaux, C.1
Paesmans, M.2
Berghmans, T.3
-
61
-
-
0027992052
-
Randomized comparison of etoposide-cisplatin vs. etoposidecarboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study
-
Skarlos DV, Samantas E, Kosmidis P, et al. Randomized comparison of etoposide-cisplatin vs. etoposidecarboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study. Ann Oncol 1994;5:601-7.
-
(1994)
Ann Oncol
, vol.5
, pp. 601-607
-
-
Skarlos, D.V.1
Samantas, E.2
Kosmidis, P.3
-
62
-
-
84863752868
-
Carboplatin-or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
-
Rossi A, Di Maio M, Chiodini P, et al. Carboplatin-or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012;30:1692-8.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1692-1698
-
-
Rossi, A.1
Di Maio, M.2
Chiodini, P.3
-
63
-
-
33646704639
-
Longterm follow-up of Limited stage small cell lung cancer patients treated with carboplatin-based chemotherapy and radiotherapy by the Minnie Pearl Cancer Research Network (MPCRN)
-
Spigel DR, Hainsworth JD, Burris HA, et al. Longterm follow-up of Limited stage small cell lung cancer patients treated with carboplatin-based chemotherapy and radiotherapy by the Minnie Pearl Cancer Research Network (MPCRN). J Clin Oncol 2004;22:abstr 7222.
-
(2004)
J Clin Oncol
, vol.22
-
-
Spigel, D.R.1
Hainsworth, J.D.2
Burris, H.A.3
-
64
-
-
0037050354
-
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
-
Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85-91.
-
(2002)
N Engl J Med
, vol.346
, pp. 85-91
-
-
Noda, K.1
Nishiwaki, Y.2
Kawahara, M.3
-
65
-
-
33646447066
-
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/ cisplatin in patients with previously untreated extensivestage disease small-cell lung cancer
-
Hanna N, Bunn PA Jr, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/ cisplatin in patients with previously untreated extensivestage disease small-cell lung cancer. J Clin Oncol 2006;24:2038-43.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2038-2043
-
-
Hanna, N.1
Bunn, P.A.2
Langer, C.3
-
66
-
-
66349102227
-
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124
-
Lara PN Jr, Natale R, Crowley J, et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009;27:2530-5.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2530-2535
-
-
Lara, P.N.1
Natale, R.2
Crowley, J.3
-
67
-
-
79960990421
-
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposidecarboplatin as first-line therapy for extensive-disease smallcell lung cancer
-
Schmittel A, Sebastian M, Fischer von Weikersthal L, et al. A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposidecarboplatin as first-line therapy for extensive-disease smallcell lung cancer. Ann Oncol 2011;22:1798-804.
-
(2011)
Ann Oncol
, vol.22
, pp. 1798-1804
-
-
Schmittel, A.1
Sebastian, M.2
Fischer Von Weikersthal, L.3
-
68
-
-
0035871527
-
Topotecan versus observation after cisplatin plus etoposide in extensivestage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group
-
Schiller JH, Adak S, Cella D, et al. Topotecan versus observation after cisplatin plus etoposide in extensivestage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2001;19:2114-22.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2114-2122
-
-
Schiller, J.H.1
Adak, S.2
Cella, D.3
-
69
-
-
29144480913
-
Does maintenance/ consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials
-
Bozcuk H, Artac M, Ozdogan M, et al. Does maintenance/ consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials. Cancer 2005;104:2650-7.
-
(2005)
Cancer
, vol.104
, pp. 2650-2657
-
-
Bozcuk, H.1
Artac, M.2
Ozdogan, M.3
-
70
-
-
58149346191
-
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups
-
Slotman BJ, Mauer ME, Bottomley A, et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol 2009;27:78-84.
-
(2009)
J Clin Oncol
, vol.27
, pp. 78-84
-
-
Slotman, B.J.1
Mauer, M.E.2
Bottomley, A.3
-
71
-
-
73349141727
-
New advances in the second-line treatment of small cell lung cancer
-
Hurwitz JL, McCoy F, Scullin P, et al. New advances in the second-line treatment of small cell lung cancer. Oncologist 2009;14:986-94.
-
(2009)
Oncologist
, vol.14
, pp. 986-994
-
-
Hurwitz, J.L.1
McCoy, F.2
Scullin, P.3
-
72
-
-
41749087812
-
Management of recurrent small cell lung cancer
-
Schneider BJ. Management of recurrent small cell lung cancer. J Natl Compr Canc Netw 2008;6:323-31.
-
(2008)
J Natl Compr Canc Netw
, vol.6
, pp. 323-331
-
-
Schneider, B.J.1
-
73
-
-
0023519996
-
Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy
-
Postmus PE, Berendsen HH, van Zandwijk N, et al. Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy. Eur J Cancer Clin Oncol 1987;23:1409-11.
-
(1987)
Eur J Cancer Clin Oncol
, vol.23
, pp. 1409-1411
-
-
Postmus, P.E.1
Berendsen, H.H.2
Van Zandwijk, N.3
-
74
-
-
84862142866
-
A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer
-
Owonikoko TK, Behera M, Chen Z, et al. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer. J Thorac Oncol 2012;7:866-72.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 866-872
-
-
Owonikoko, T.K.1
Behera, M.2
Chen, Z.3
-
75
-
-
0033044111
-
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer
-
von Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 1999;17:658-67.
-
(1999)
J Clin Oncol
, vol.17
, pp. 658-667
-
-
Von Pawel, J.1
Schiller, J.H.2
Shepherd, F.A.3
-
76
-
-
34247218552
-
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
-
O'Brien ME, Ciuleanu TE, Tsekov H, et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 2006;24:5441-7.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5441-5447
-
-
O'Brien, M.E.1
Ciuleanu, T.E.2
Tsekov, H.3
-
77
-
-
65349157711
-
Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer
-
Eckardt JR, Bentsion DL, Lipatov ON, et al. Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer. J Clin Oncol 2009;27:2046-51.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2046-2051
-
-
Eckardt, J.R.1
Bentsion, D.L.2
Lipatov, O.N.3
-
78
-
-
34247197121
-
Phase II trial of amrubicin for treatment of refractory or relapsed smallcell lung cancer: Thoracic Oncology Research Group Study 0301
-
Onoda S, Masuda N, Seto T, et al. Phase II trial of amrubicin for treatment of refractory or relapsed smallcell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol 2006;24:5448-53.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5448-5453
-
-
Onoda, S.1
Masuda, N.2
Seto, T.3
-
79
-
-
84918588050
-
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer
-
von Pawel J, Jotte R, Spigel DR, et al. Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer. J Clin Oncol 2014;32:4012-9.
-
(2014)
J Clin Oncol
, vol.32
, pp. 4012-4019
-
-
von Pawel, J.1
Jotte, R.2
Spigel, D.R.3
-
80
-
-
0036983552
-
ZD0473 treatment in lung cancer: an overview of the clinical trial results
-
Treat J, Schiller J, Quoix E, et al. ZD0473 treatment in lung cancer: an overview of the clinical trial results. Eur J Cancer 2002;38 Suppl 8:S13-8.
-
(2002)
Eur J Cancer
, vol.38
, pp. S13-S18
-
-
Treat, J.1
Schiller, J.2
Quoix, E.3
-
81
-
-
78049366860
-
Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy
-
Ciuleanu T, Samarzjia M, Demidchik Y, et al. Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy. J Clin Oncol 2010;28:abstr 7002.
-
(2010)
J Clin Oncol
, vol.28
-
-
Ciuleanu, T.1
Samarzjia, M.2
Demidchik, Y.3
-
82
-
-
79952192731
-
A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer
-
Rhee CK, Lee SH, Kim JS, et al. A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer. Lung Cancer 2011;72:64-7.
-
(2011)
Lung Cancer
, vol.72
, pp. 64-67
-
-
Rhee, C.K.1
Lee, S.H.2
Kim, J.S.3
-
83
-
-
77956185923
-
Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial
-
Jeong J, Cho BC, Sohn JH, et al. Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial. Lung Cancer 2010;70:77-81.
-
(2010)
Lung Cancer
, vol.70
, pp. 77-81
-
-
Jeong, J.1
Cho, B.C.2
Sohn, J.H.3
-
84
-
-
84863344528
-
Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients
-
Kim GM, Kim YS, Ae Kang Y, et al. Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients. J Thorac Oncol 2012;7:731-6.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 731-736
-
-
Kim, G.M.1
Kim, Y.S.2
Ae Kang, Y.3
-
85
-
-
84896264786
-
Chemotherapy advances in smallcell lung cancer
-
Chan BA, Coward JI. Chemotherapy advances in smallcell lung cancer. J Thorac Dis 2013;5 Suppl 5:S565-78.
-
(2013)
J Thorac Dis
, vol.5
, pp. S565-S578
-
-
Chan, B.A.1
Coward, J.I.2
-
86
-
-
84911472338
-
Advances in pharmacotherapy of small cell lung cancer
-
Kalemkerian GP. Advances in pharmacotherapy of small cell lung cancer. Expert Opin Pharmacother 2014;15:2385-96.
-
(2014)
Expert Opin Pharmacother
, vol.15
, pp. 2385-2396
-
-
Kalemkerian, G.P.1
|